Production (Stage)
Neuphoria Therapeutics Inc.
NEUP
$6.87
-$0.28-3.92%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 68.20% | -57.13% | -33.22% | 4.17% | -16.27% |
| Total Receivables | -- | -91.59% | -- | -70.22% | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -98.02% | -- | -42.47% | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -- | -61.72% | -- | -1.00% | -- |
|
|
|||||
| Total Current Assets | -- | -61.72% | -- | -1.00% | -- |
| Net Property, Plant & Equipment | -- | -46.35% | -- | -34.23% | -- |
| Long-term Investments | -- | -4.75% | -- | -0.05% | -- |
| Goodwill | -- | -4.75% | -- | -0.05% | -- |
| Total Other Intangibles | -- | -11.49% | -- | -10.81% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -8.75% | -- | -0.13% | -- |
| Total Assets | -- | -31.40% | -- | -3.20% | -- |
|
|
|||||
| Total Accounts Payable | -- | -12.39% | -- | 55.89% | -- |
| Total Accrued Expenses | -- | 26.80% | -- | 23.43% | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -1.58% | -- | 7.11% | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -- | -29.23% | -- | 39.81% | -- |
|
|
|||||
| Total Current Liabilities | -- | -29.23% | -- | 39.81% | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -73.15% | -- | -50.96% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -35.97% | -- | 73.82% | -- |
| Total Liabilities | -- | -33.96% | -- | 55.04% | -- |
|
|
|||||
| Common Stock & APIC | -- | 24.34% | -- | 5.83% | -- |
| Retained Earnings | -- | -21.27% | -- | -9.53% | -- |
| Treasury Stock & Other | -- | -139.41% | -- | 1.48% | -- |
| Total Common Equity | 31.36% | -30.53% | -22.44% | -20.54% | -10.09% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 31.36% | -30.53% | -22.44% | -20.54% | -10.09% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 31.36% | -30.53% | -22.44% | -20.54% | -10.09% |
|
|
|||||